肺动脉高压对风湿性二尖瓣狭窄患者临床结局的影响
该回顾性队列纳入394例风湿性二尖瓣狭窄行二尖瓣置换术患者,按术前有无肺动脉高压(sPAP>50 mm Hg)分组。术后sPAP和RVSP显著下降可降低三尖瓣反流进展风险。
要点
- 二尖瓣置换术时合并肺动脉高压与远期生存率降低相关。
- 术前sPAP和RVSP水平不影响三尖瓣反流进展。
- 术后sPAP和RVSP显著下降可预防三尖瓣反流进展。
核心结论
- 二尖瓣置换术时合并肺动脉高压与较差的远期生存相关,但充分的sPAP和RVSP下降可预防三尖瓣反流进展,即使术前存在重度肺动脉高压。
研究设计与样本
- 肺动脉高压定义为收缩期肺动脉压(sPAP)>50 mm Hg,非肺动脉高压组322例,肺动脉高压组72例。
临床怎么用
- 二尖瓣置换术后应仔细监测肺动脉压和右心室收缩压,并努力降低术后肺动脉压。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Long-term outcomes of mitral valve replacement (MVR) recipients with pulmonary hypertension (PH) remain unclear. We determined the effect of concomitant PH on the clinical outcomes and late-onset progression of tricuspid regurgitation (TR) after MVR for rheumatic mitral stenosis. METHODS: We retrospectively reviewed 394 patients who underwent MVR between January 2000 and December 2013. PH was defined as systolic pulmonary arterial pressure (sPAP) >50 mm Hg. Changes in echocardiographic parameters (preoperative to postoperative), TR progression (grade ≥ II), and long-term survival were evaluated according to the presence of PH at MVR (non-PH, n = 322; PH, n = 72). RESULTS: The 10-year overall survival rate was significantly lower in the PH group (79.7% vs 90.7%, P = .04), whereas the rate of freedom from TR progression was similar between groups (76.9% vs 80.5%, P = .373). High preoperative sPAP and right ventricular systolic pressure (RVSP) did not affect TR progression. However, substantial postoperative reductions in sPAP and RVSP protected against TR progression (hazard ratio [95% confidence interval], 0.966 [0.942-0.991], P = .008, and 0.973 [0.960-0.986], P < .001, respectively). The 10-year rate of freedom from TR progression was significantly higher in patients with substantial sPAP and RVSP reductions (sPAP, 84.2% vs 70.6%, P = .003; RVSP, 84.9% vs 71.0%, P < .001). CONCLUSIONS: Although concomitant PH at MVR is associated with poor long-term survival, adequate sPAP and RVSP reduction can prevent TR progression even in patients with severe PH preoperatively. Therefore, we suggest careful monitoring of PAP and RVSP after MVR and should make an effort to reduce postoperative PAP.
引用
- Kim DJ, Lee S, Joo HC, et al. Effect of Pulmonary Hypertension on Clinical Outcomes in Patients With Rheumatic Mitral Stenosis. Ann Thorac Surg. 2019. PMID: 31336071. doi:10.1016/j.athoracsur.2019.05.077
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。